期刊文献+

手术切除原发性肝癌42例疗效分析 被引量:6

Surgical treatment for 42 cases of primary liver cancer
原文传递
导出
摘要 目的总结原发性肝癌的外科治疗经验,评估其疗效和安全性并进一步探讨提高原发性肝癌切除术后患者生存率的方法。方法回顾分析本院2003年10月至2009年12月经外科治疗的42例原发性肝癌患者的临床资料、手术方式和随访结果。结果 42例均获手术切除。术后并发症包括出血3例,胆漏2例,膈下积液3例,上消化道出血1例,肝昏迷1例。手术死亡率2.38%。随访1年生存38例,2年生存30例,3年生存25例,术后1、2、3年复发率分别为14.3%、35.7%、42.9%。结论原发性肝癌首选治疗方法是手术切除。 Objective To summerize our experience in the surgical treatment of primary liver cancer and to evaluate the theraputic effects of hepatectomy at elevating postoperative survival of patients with primary liver cancer. Methods The clinical data of 42 patients received hepatectomy from October 2003 to December 2009 were retrospectively analyzed. Results Forty-two cases received hepatectomy operation. Postoperative complications included bleeding in 3 cases, bile leakage in 2 cases, subphrenic effusion in 3 cases, upper gastrointestinal bleeding in 1 case, 1 case of hepatic coma. The mortality was 2.38%. The 1-,2-,3-year postoperative recurrence rate were 14.3%, 35.7% and 42.9% respectively. Conclusion Hepatectomy is the chief choice in the treatment of primary liver cancer,which has good efficacy and few complications.
出处 《中华普通外科学文献(电子版)》 2011年第4期37-38,共2页 Chinese Archives of General Surgery(Electronic Edition)
关键词 原发性肝癌 肝切除术 Primary liver cancer Hepatectomy
  • 相关文献

参考文献9

  • 1Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology, 2005, 42(5): 1208-1236.
  • 2雷正明.原发性肝癌的手术治疗[J].肿瘤预防与治疗,2008,21(3):249-252. 被引量:3
  • 3Melendez JA, Arslan V, Fischer ME, et al. Pedoperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg, 1998, 187(6): 620-625.
  • 4de Boer MT, Molenaar IQ, Porte RJ. Impact of blood loss on outcome after liver resection. Dig Surg, 2007, 24(4): 259-264.
  • 5李坚,张阳德,刘恕,李年丰,李浩.选择性半肝血流阻断在肝癌半肝切除术中的应用研究[J].中国现代医学杂志,2006,16(15):2331-2333. 被引量:15
  • 6黄志强.外科手术学.3版.北京:人民卫生出版社,2004:931-932.
  • 7Maleux G, van Malenstein H, Vandecaveye V, et al. Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions. Dig Dis, 2009, 27(2): 157-163.
  • 8杜临安,姜波.肝癌介入治疗的价值及选择[J].肝胆外科杂志,2010,18(1):11-14. 被引量:9
  • 9Chua TC, Liauw W, Saxena A, et al. Systematic review of neoadjuvanl transarterial chemoembolization for resectable hepatocellular carcinoma. Liver Int, 2010, 30(2): 166-174.

二级参考文献15

共引文献24

同被引文献32

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部